Pages that link to "Q35911107"

The following pages link to Identification of N-acetyltransferase 2 (NAT2) transcription start sites and quantitation of NAT2-specific mRNA in human tissues. (Q35911107):

Displaying 38 items.

• Multiple advantageous amino acid variants in the NAT2 gene in human populations (Q21144240) (← links)
• Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery (Q26995125) (← links)
• PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2 (Q27011622) (← links)
• Quantitative tissue and gene-specific differences and developmental changes in Nat1, Nat2, and Nat3 mRNA expression in the rat (Q28583635) (← links)
• 4-Aminobiphenyl downregulation of NAT2 acetylator genotype-dependent N- and O-acetylation of aromatic and heterocyclic amine carcinogens in primary mammary epithelial cell cultures from rapid and slow acetylator rats (Q29347040) (← links)
• Polymorphisms of promoter and coding regions of the arylamine N-acetyltransferase 2 (NAT2) gene in the Indonesian population: proposal for a new nomenclature. (Q30839905) (← links)
• Bioactivation of the human carcinogen aristolochic acid (Q34009989) (← links)
• The pharmacogenetics of NAT2 enzyme maturation in perinatally HIV exposed infants receiving isoniazid (Q35238140) (← links)
• Variation in NAT2 acetylation phenotypes is associated with differences in food-producing subsistence modes and ecoregions in Africa (Q35856283) (← links)
• mRNA expression of metabolic enzymes in human cornea, corneal cell lines, and hemicornea constructs (Q35990861) (← links)
• Computational and experimental analyses of mammalian arylamine N-acetyltransferase structure and function (Q36158467) (← links)
• Functional analysis of the human N-acetyltransferase 1 major promoter: quantitation of tissue expression and identification of critical sequence elements. (Q36158490) (← links)
• Tissue expression and genomic sequences of rat N-acetyltransferases rNat1, rNat2, rNat3, and Functional characterization of a novel rNat3*2 genetic variant (Q36168750) (← links)
• Characterization of genetic variation and natural selection at the arylamine N-acetyltransferase genes in global human populations (Q36301606) (← links)
• Interaction of the cytochrome P4501A2, SULT1A1 and NAT gene polymorphisms with smoking and dietary mutagen intake in modification of the risk of pancreatic cancer (Q36743654) (← links)
• Systemic functional expression of N-acetyltransferase polymorphism in the F344 Nat2 congenic rat. (Q37000797) (← links)
• Update on the pharmacogenetics of NATs: structural considerations (Q37329162) (← links)
• Differential association for N-acetyltransferase 2 genotype and phenotype with bladder cancer risk in Chinese population (Q37457764) (← links)
• Genetic polymorphism in N-Acetyltransferase (NAT): Population distribution of NAT1 and NAT2 activity (Q37698414) (← links)
• Extrahepatic metabolism at the body's internal-external interfaces. (Q38199198) (← links)
• Biotransformation of xenobiotics in the human colon and rectum and its association with colorectal cancer (Q38357424) (← links)
• Gene-environment interactions in esophageal cancer (Q38556530) (← links)
• Role of human sulfotransferase 1A1 and N-acetyltransferase 2 in the metabolic activation of 16 heterocyclic amines and related heterocyclics to genotoxicants in recombinant V79 cells (Q38979808) (← links)
• Xenobiotic metabolizing enzyme activities in cells used for testing skin sensitization in vitro (Q39108182) (← links)
• Polymorphisms in NAT2 Gene and Atherosclerosis in an Algerian Population (Q39133736) (← links)
• Ocular non-P450 oxidative, reductive, hydrolytic, and conjugative drug metabolizing enzymes (Q39259079) (← links)
• A long-lived luminescent probe to sensitively detect arylamine N-acetyltransferase (NAT) activity of cells. (Q39410980) (← links)
• Cloning and characterization of the rat lysyl oxidase gene promoter: identification of core promoter elements and functional nuclear factor I-binding sites (Q40114338) (← links)
• Simulation of chemical metabolism for fate and hazard assessment. V. Mammalian hazard assessment (Q46109800) (← links)
• Arylamine N-acetyltransferase 1 in situ N-acetylation on CD3+ peripheral blood mononuclear cells correlate with NATb mRNA and NAT1 haplotype (Q47636095) (← links)
• A case-control study of Parkinson's disease and tobacco use: gene-tobacco interactions. (Q54428505) (← links)
• Retrospective analysis of estrogen receptor 1 and N‑acetyltransferase gene expression in normal breast tissue, primary breast tumors, and established breast cancer cell lines. (Q55503255) (← links)
• Pharmacogenetic association between gene polymorphisms and isoniazid induced hepatotoxicity: trial sequence meta-analysis as evidence (Q61447894) (← links)
• N-acetyltransferase SNPs: emerging concepts serve as a paradigm for understanding complexities of personalized medicine (Q83687295) (← links)
• Human arylamine N-acetyltransferase 2 genotype-dependent protein expression in cryopreserved human hepatocytes (Q94555319) (← links)
• Study on Genotyping Polymorphism and Sequencing of N-Acetyltransferase 2 (NAT2) among Al-Ahsa Population (Q97075128) (← links)
• Arylamine N-acetyltransferase acetylation polymorphisms: paradigm for pharmacogenomic-guided therapy- a focused review (Q100950427) (← links)
• Acetylation of putative arylamine and alkylaniline carcinogens in immortalized human fibroblasts transfected with rapid and slow acetylator N-acetyltransferase 2 haplotypes (Q101152501) (← links)